Dexcom (DXCM) Total Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Total Liabilities data on file, last reported at $3.7 billion in Q1 2026.

• Total Liabilities for Q1 2026 came in at $3.7 billion, down 18.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 billion (down 18.03% YoY), and the FY2025 annual result was $3.6 billion, down 17.98% from the prior year.
• Total Liabilities grew to $3.7 billion in Q1 2026 per DXCM's latest filing, from $3.6 billion in the prior quarter.
• Over five years, Total Liabilities peaked at $4.8 billion in Q3 2025 and troughed at $2.9 billion in Q1 2022.
• A 5-year average of $4.0 billion and a median of $4.2 billion in 2024 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2026: Total Liabilities surged 59.39% in 2023, then declined 18.03% in 2026.
• A 5-year view of Total Liabilities shows it stood at $3.3 billion in 2022, then grew by 28.71% to $4.2 billion in 2023, then rose by 4.43% to $4.4 billion in 2024, then decreased by 17.98% to $3.6 billion in 2025, then increased by 2.3% to $3.7 billion in 2026.
• Business Quant data shows DXCM's Total Liabilities at $3.7 billion in Q1 2026, $3.6 billion in Q4 2025, and $4.8 billion in Q3 2025.